Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioMarin Pharmaceutical
Biotech
Midsize biotechs form coalition to fight against MFN policy
A group of 10 domestic, medium-sized biotechs launched the Midsized Biotech Alliance of America to advocate for free-market solutions to drug policy.
Will Maddox
Feb 25, 2026 1:05pm
RFK Jr. continues overhaul of CDC vaccine panel—Chutes & Ladders
Jan 16, 2026 8:30am
After $4.8B Amicus buy, BioMarin drops genetic disease asset
Dec 22, 2025 11:12am
Sanofi snags BioMarin leader to serve as CMO
Aug 26, 2025 11:06am
BioMarin drops PKU drug once seen as possible Palynziq successor
Aug 5, 2025 4:48am
BioMarin inks $270M Inozyme buyout, bagging phase 3 prospect
May 16, 2025 8:46am
